BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6090834)

  • 1. Enhancement of opiate-induced depressions in serum luteinizing hormone levels by the prior administration of naloxone in the male rat.
    Cicero TJ; Owens DP; Schmoeker PF; Meyer ER
    Life Sci; 1984 Sep; 35(12):1321-8. PubMed ID: 6090834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous and endogenous opioid-induced enhancements of naloxone's effects on serum luteinizing hormone levels in the male rat.
    Cicero TJ; Owens DP; Newman KS; Schmoeker PF; Meyer ER
    Eur J Pharmacol; 1984 Oct; 105(3-4):273-84. PubMed ID: 6096156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related differences in the sensitivity of serum luteinizing hormone to prototypic mu, kappa and delta opiate agonists and antagonists.
    Cicero TJ; Meyer ER; Miller BT; Bell RD
    J Pharmacol Exp Ther; 1988 Jul; 246(1):14-20. PubMed ID: 2839658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opiate-induced enhancement of the effects of naloxone on serum luteinizing hormone levels in the male rat: specificity for Mu agonists.
    Cicero TJ; Owens DP; Schmoeker PF; Meyer ER
    J Pharmacol Exp Ther; 1983 Sep; 226(3):770-5. PubMed ID: 6310081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteinizing hormone releasing hormone mediates naloxone's effects on serum luteinizing hormone levels in normal and morphine-sensitized male rats.
    Cicero TJ; Schmoeker PF; Meyer ER; Miller BT
    Life Sci; 1985 Aug; 37(5):467-74. PubMed ID: 3894852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine-induced supersensitivity to the effects of naloxone on luteinizing hormone secretion in the male rat.
    Cicero TJ; Owens DP; Schmoeker PF; Meyer ER
    J Pharmacol Exp Ther; 1983 Apr; 225(1):35-41. PubMed ID: 6682144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontogeny of the opioid-mediated control of reproductive endocrinology in the male and female rat.
    Cicero TJ; Schmoeker PF; Meyer ER; Miller BT; Bell RD; Cytron SM; Brown CC
    J Pharmacol Exp Ther; 1986 Mar; 236(3):627-33. PubMed ID: 3512817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid effects on plasma concentrations of luteinizing hormone and prolactin in the adult male rhesus monkey.
    Gilbeau PM; Almirez RG; Holaday JW; Smith CG
    J Clin Endocrinol Metab; 1985 Feb; 60(2):299-305. PubMed ID: 2981242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opiate withdrawal-induced hyposensitivity to naloxone's effects on serum luteinizing hormone in the male rat.
    Cicero TJ; Aleem A; Meyer ER; Schmoeker PF; Miller BT
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1063-70. PubMed ID: 3528453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid-induced suppression of rat testicular function.
    Adams ML; Sewing B; Forman JB; Meyer ER; Cicero TJ
    J Pharmacol Exp Ther; 1993 Jul; 266(1):323-8. PubMed ID: 8392556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid regulation of luteinizing hormone secretion in the male rat.
    Miller MA; Bremner WJ; Clifton DK; Dorsa DM; Steiner RA
    Biol Reprod; 1986 Aug; 35(1):17-26. PubMed ID: 3741948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone does not reverse the inhibitory effect of morphine on luteinizing hormone secretion in prepubescent male rats.
    Cicero TJ; Nock B; O'Connor L
    J Pharmacol Exp Ther; 1993 Jan; 264(1):47-53. PubMed ID: 8380870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central, stereoselective receptors mediate the acute effects of opiate antagonists on luteinizing hormone secretion.
    Blank MS; Mann DR; Daugherty DT; Sridiran R; Murphy JR
    Life Sci; 1986 Oct; 39(17):1493-99. PubMed ID: 3020332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone-induced increases in serum luteinizing hormone in the male: mechanisms of action.
    Cicero TJ; Wilcox CE; Bell RD; Meyer ER
    J Pharmacol Exp Ther; 1980 Mar; 212(3):573-8. PubMed ID: 6244390
    [No Abstract]   [Full Text] [Related]  

  • 15. Endogenous opioids participate in the regulation of the hypothalamus-pituitary-luteinizing hormone axis and testosterone's negative feedback control of luteinizing hormone.
    Cicero TJ; Schainker BA; Meyer ER
    Endocrinology; 1979 May; 104(5):1286-91. PubMed ID: 374068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonist of gonadotropin-releasing hormone blocks naloxone-induced elevations in serum luteinizing hormone.
    Blank MS; Roberts DL
    Neuroendocrinology; 1982 Nov; 35(5):309-12. PubMed ID: 6755289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethanol inhibits the naloxone-induced release of luteinizing hormone-releasing hormone from the hypothalamus of the male rat.
    Cicero TJ; Newman KS; Gerrity M; Schmoeker PF; Bell RD
    Life Sci; 1982 Oct; 31(15):1587-96. PubMed ID: 6755122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opiatergic control of gonadotropin secretion during puberty in the rat: a neurochemical basis for the hypothalamic 'gonadostat'?
    Bhanot R; Wilkinson M
    Endocrinology; 1983 Aug; 113(2):596-603. PubMed ID: 6409589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominant involvement of mu-rather than delta- or kappa-opiate receptors in LH secretion.
    Pfeiffer DG; Pfeiffer A; Shimohigashi Y; Merriam GR; Loriaux DL
    Peptides; 1983; 4(5):647-9. PubMed ID: 6318200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous opioid peptide regulation of pulsatile luteinizing hormone secretion during pregnancy in the rat.
    Devorshak-Harvey E; Bona-Gallo A; Gallo RV
    Neuroendocrinology; 1987 Nov; 46(5):369-78. PubMed ID: 3323939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.